Pacific Biosciences of California, Inc. (PACB) vs SS Innovations International, Inc. (SSII)

Pacific Biosciences of California, Inc. and SS Innovations International, Inc. are both Medical Devices companies. SS Innovations International, Inc. is the larger, with a market value of $591.4M against $484.9M — 1.2× the size. SS Innovations International, Inc. grew revenue faster over the last twelve months: 89.7% against 2.02%. SS Innovations International, Inc. has the higher net margin (−23.7% vs −82.5%) and the higher return on invested capital (−11.3% vs −22.2%). Across the 16 metrics below, SS Innovations International, Inc. leads on 11 and Pacific Biosciences of California, Inc. on 5.

Valuation

Metric PACB SSII Medical Devices median
P/E n/m n/m 22.18
P/S 3.16 11.27 2.70
P/B n/m 11.06 2.46
Price to free cash flow n/m n/m 22.53
EV/EBITDA n/m n/m 11.78
EV/Sales 5.72 11.12 2.38
Earnings yield (26.54%) (2.03%) (8.22%)
Free cash flow yield (15.99%) (3.09%) (7.80%)

Profitability

Metric PACB SSII Medical Devices median
Gross margin 36.38% 47.65% 56.01%
Operating margin (83.53%) (15.80%) (15.03%)
Net margin (82.49%) (23.73%) (20.40%)
Free cash flow margin (50.53%) (34.76%) (7.24%)
Return on equity (929.31%) (26.06%) (15.32%)
Return on assets (16.66%) (14.89%) (19.72%)
Return on invested capital (22.22%) (11.31%) (10.33%)

Growth

Metric PACB SSII Medical Devices median
Revenue growth (TTM) 2.02% 89.71% 8.80%
EPS growth (last fiscal year) (69.38%) 43.24% —
Revenue growth, 5-year CAGR 15.19% — 15.23%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PACB SSII Medical Devices median
Debt to equity (19.40) 0.27 0.07
Current ratio 4.92 2.24 2.50
Net debt to EBITDA (2.33) (0.32) 0.49

Dividend

Metric PACB SSII Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 — 0.00

Size

Metric PACB SSII Medical Devices median
Market cap 484.89m 591.41m 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack